1.
Iron Oxide Nanoparticles for Magnetically-Guided and Magnetically-Responsive Drug Delivery
by Estelrich, Joan
2015
International Journal of Molecular Sciences, pp.8070-8101
2015

2.
Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach
by Lu, Yao
Cancer Letters, 28 August 2016, Vol.379(1), pp.32-38

3.
Medium-chain fatty acid nanoliposomes suppress body fat accumulation in mice
by Liu, Wei-lin
British Journal of Nutrition, 2011, Vol.106(9), pp.1330-1336

4.
Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma
by Kim, Sang-Soo
Cancer Letters, 01 December 2015, Vol.369(1), pp.250-258

5.
Drug Delivery System of Anti-fungal and Parasitic Agents
by Maesaki, Shigefumi
Current Pharmaceutical Design, 2002, Vol.8(6), p.433-440

6.
Sustained broad-spectrum antibacterial effects of nanoliposomes loaded with silver nanoparticles
by Eid, Kamel A M
Nanomedicine (London, England), July 2014, Vol.9(9), pp.1301-10

7.
Liposomes produced by reverse phase evaporation: in vitro and in vivo efficacy of diminazene aceturate against Trypanosoma evansi
by Oliveira, Camila Belmonte
Parasitology, 2014, Vol.141(6), pp.761-769

8.
Nanocarriers for vascular delivery of antioxidants
by Hood, Elizabeth
Nanomedicine, Sep 2011, pp.1257-72

9.
Liposome-based delivery system for vaccine candidates: constructing an effective formulation
by Giddam, Ashwini Kumar
Nanomedicine, Dec 2012, pp.1877-93

10.
New Dual Mode Gadolinium Nanoparticle Contrast Agent for Magnetic Resonance Imaging (Nanoparticle Agent for MRI)
by Ghaghada, Ketan B
PLoS ONE, 2009, Vol.4(10), p.e7628

11.
Pharmacokinetics and Dosimetry of 111In/188Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models
by Lin, Yi-Yu
Cancer Biotherapy & Radiopharmaceuticals, 01 June 2011, Vol.26(3), pp.373-380

12.
In vivo evaluation of PEGylated 64 Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT
by Petersen, Anncatrine
European Journal of Nuclear Medicine and Molecular Imaging, 2016, Vol.43(5), pp.941-952

13.
Membrane interaction and antibacterial properties of two mildly cationic peptide diastereomers, bombinins H2 and H4, isolated from Bombina skin
by Coccia, Cristina
European Biophysics Journal, 2011, Vol.40(4), pp.577-588

14.
Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide [mu] (mu) and plasmid DNA
by Tagawa, T
Gene Therapy, May 2002, pp.564-76

15.
Nonionic surfactant vesicles for delivery of RNAi therapeutics.(RNA interference)(Report)
by Paecharoenchai, Orapan
Nanomedicine, Nov, 2013, Vol.8(11), p.1865(9)

16.
Nanomedicine strategies for drug delivery to the ear.(Report)
by Pritz, Christian Oliver
Nanomedicine, July, 2013, Vol.8(7), p.1155(18)

17.
Efficient intracellular delivery of siRNA with a safe multitargeted lipid-based nanoplatform
by Gomes-Da-Silva, Lígia
Nanomedicine, Sep 2013, pp.1397-413

18.
Nanodetoxification: emerging role of nanomaterials in drug intoxication treatment
by Graham, Lauren
Nanomedicine, Jul 2011, pp.921-8

19.
Bone marrow-targeted liposomal carriers: a feasibility study in nonhuman primates
by Sou, Keitaro
Nanomedicine, Jan 2010, pp.41-9

20.
Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids
by Elizondo, Elisa
Nanomedicine, Sep 2012, pp.1391-408
